Myopia Control Effect of DIMS Spectacle Lenses in Czech Children and Young Adults
NCT ID: NCT05943912
Last Updated: 2024-04-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
80 participants
OBSERVATIONAL
2023-04-17
2026-12-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of DIMS Spectacle as a Function of the Age
NCT06556849
DIMS-myopia Progression ADN Axial Length Growth
NCT05300321
To Evaluate the Efficacy and Safety of an Defocus Lens in Slowing the Progression of Myopia
NCT06405711
The Immediate Effect of Defocus Spectacles On the Choroid Thickness Using Optical Coherence Tomography on Children
NCT06234189
Myopia Control Efficacy of Second-generation DIMS Spectacle Lenses on Fast Progressing Myopes
NCT05888792
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Defocus incorporated multiple segments (DIMS) spectacle lenses were designed to slow myopia progression in children, based on the principle of peripheral myopic defocus. DIMS spectacles reduce the progression of myopia and reduce axial elongation by 50-60% compared to single vision (SV) lenses according to previous scientific studies conducted mostly on the Asian population under the age of 15.
The majority of myopia appears and progresses during childhood. The myopia stabilizes by the age of 18 years, a number of individuals may still present myopic changes.
The goals of our study:
* compare the efficacy of DIMS spectacle lenses with SV spectacle lenses at slowing the progression of myopia in the category of Czech children and young adults (effect on axial length and refractive changes)
* monitoring axial length and refractive changes in myopic children and young adults (aged 6-26)
* monitoring adaptation to DIMS lenses in myopes aged 6-26 years monitoring the influence of the environment and individual behavior on the progression of myopia
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Single Vision Spectacle Lens
Participants who chose to correct myopia with single vision spectacle lenses.
Single Vision Spectacle Lens
36 months of therapy
Defocus Incorporated Multiple Segments (DIMS) Spectacle Lens
Participants who chose to correct myopia with DIMS spectacle lenses.
Defocus Incorporated Multiple Segments (DIMS) Spectacle Lens
36 months of therapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Single Vision Spectacle Lens
36 months of therapy
Defocus Incorporated Multiple Segments (DIMS) Spectacle Lens
36 months of therapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Myopes aged 6-26 years
* Myopia between -0,25D and -8,5D
* Astigmatism -0,25 and -2,25DC
Exclusion Criteria
* Amblyopia
* Strabism
* Non-compliance to eye examinations
6 Years
26 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Czech Technical University in Prague
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marketa Zakova, Ph.D.
Role: STUDY_DIRECTOR
Czech Technical University in Prague
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Czech Technical University
Prague, Czech Republic, Czechia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SGS23/195/OHK4/3T/17
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.